Chiron Capital Management, LLC Oncolytics Biotech Inc Transaction History

Chiron Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$1.39 - $2.3 $14,177 - $23,460	-10,200 Closed	0 $0
Q2 2021 Jul 20, 2021	BUY	$2.6 - $4.64 $520 - $927	200 Added 2.0%	10,200 $28,000
Q1 2021 May 18, 2021	BUY	$2.32 - $4.11 $23,200 - $41,100	10,000 New	10,000 $38,000
Q4 2020 Mar 05, 2021	SELL	$1.71 - $4.03 $5,985 - $14,105	-3,500 Closed	0 $0
Q3 2020 Nov 19, 2020	BUY	$1.58 - $2.15 $5,530 - $7,525	3,500 New	3,500 $6,000

1.21M

Ticker ONCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,867,400
Market Cap $49.2M
Description
Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...

Get notified when there are updates to the investment portfolio of Chiron Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Chiron Capital Management, LLC with notifications on news.